☆ 4.7 Letter

Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab-Response

CLINICAL CANCER RESEARCH (2020)

Get Full Text
Add to Collection

Journal

CLINICAL CANCER RESEARCH
Volume 26, Issue 10, Pages 2436-2436

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-20-0298

Keywords

-

Categories

Oncology

Funding

  1. F. Hoffmann-La Roche Ltd/Genentech, Inc. of the Roche Group

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.